The PsychENCODE Consortium was founded by the U.S. National Institutes of Health in 2015 to study the role of rare genetic variants involved in several psychiatric disorders. PsychENCODE aims to create a public resource of genomic data gathered from 1,000 healthy and disease-affected post-mortem brains reflecting different developmental periods.

PsychENCODE will first focus on autism spectrum disorder, bipolar disorder, and schizophrenia, and then move on to other disorders.

PsychENCODE Consortium

Participating organizations

As of December 2018, participating organizations include:

PsychENCODE Consortium

Duke University

Icahn School of Medicine at Mount Sinai

Johns Hopkins University

Lieber Institute for Brain Development

Mayo Clinic

National Institute of Mental Health

Sage Bionetworks

SUNY Downstate Medical University

SUNY Upstate Medical University

University of California Los Angeles

University of Chicago

University of Illinois

University of Massachusetts Medical School

University of North Carolina

University of Southern California

Yale University

References

Consortia in the United States

2015 establishments in the United States

National Institutes of Health

Psychiatric research

PsychENCODE Consortium